Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma-Reference-Cited by-同舟云学术

Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma

Published:2020-05-29 Issue:6 Volume:26 Page:909-918
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Braun David A.^ORCID,Hou Yue,Bakouny Ziad^ORCID,Ficial Miriam^ORCID,Sant’ Angelo Miriam,Forman Juliet,Ross-Macdonald Petra,Berger Ashton C.,Jegede Opeyemi A.,Elagina Liudmilla,Steinharter John,Sun Maxine,Wind-Rotolo Megan,Pignon Jean-Christophe,Cherniack Andrew D.,Lichtenstein Lee,Neuberg Donna^ORCID,Catalano Paul,Freeman Gordon J.^ORCID,Sharpe Arlene H.^ORCID,McDermott David F.^ORCID,Van Allen Eliezer M.^ORCID,Signoretti Sabina,Wu Catherine J.^ORCID,Shukla Sachet A.^ORCID,Choueiri Toni K.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/s41591-020-0839-y.pdf

Reference77 articles.

1. Ribas, A. & Wolchok, J. D. Cancer immunotherapy using checkpoint blockade. Science 359, 1350–1355 (2018).

2. Motzer, R. J. et al. Nivolumab versus everolimus in advanced renal-cell carcinoma. N. Engl. J. Med. 373, 1803–1813 (2015).

3. Motzer, R. J. et al. Avelumab plus axitinib versus sunitinib for advanced renal-cell carcinoma. N. Engl. J. Med. 380, 1103–1115 (2019).

4. Motzer, R. J. et al. Nivolumab plus ipilimumab versus sunitinib in advanced renal-cell carcinoma. N. Engl. J. Med. 378, 1277–1290 (2018).

5. Rini, B. I. et al. Pembrolizumab plus axitinib versus sunitinib for advanced renal-cell carcinoma. N. Engl. J. Med. 380, 1116–1127 (2019).

Cited by 598 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive genomic and spatial immune infiltration analysis of survival outliers in extensive-stage small cell lung cancer receiving first-line chemoimmunotherapy;International Immunopharmacology;2024-11

2. Prognostic Impact and Genomic Backgrounds of Renal Parenchymal Infiltration or Micronodular Spread in Nonmetastatic Clear Cell Renal Cell Carcinoma;Modern Pathology;2024-11

3. Integrative analysis of pan-cancer single-cell data reveals a tumor ecosystem subtype predicting immunotherapy response;npj Precision Oncology;2024-09-15

4. Single-cell profiling uncovers proliferative cells as key determinants of survival outcomes in lower-grade glioma patients;Discover Oncology;2024-09-14

5. Syndecan-1 inhibition promotes antitumor immune response and facilitates the efficacy of anti-PD1 checkpoint immunotherapy;Science Advances;2024-09-13